Brown and beige adipose tissues can dissipate chemical energy as heat through thermogenic respiration, which requires uncoupling protein 1 (UCP1) 1,2 . Thermogenesis from these adipocytes can combat obesity and diabetes 3 , encouraging investigation of factors that control UCP1-dependent respiration in vivo. Here we show that acutely activated thermogenesis in brown adipose tissue is defined by a substantial increase in levels of mitochondrial reactive oxygen species (ROS). Remarkably, this process supports in vivo thermogenesis, as pharmacological depletion of mitochondrial ROS results in hypothermia upon cold exposure, and inhibits UCP1-dependent increases in whole-body energy expenditure. We further establish that thermogenic ROS alter the redox status of cysteine thiols in brown adipose tissue to drive increased respiration, and that Cys253 of UCP1 is a key target. UCP1 Cys253 is sulfenylated during thermogenesis, while mutation of this site desensitizes the purine-nucleotide-inhibited state of the carrier to adrenergic activation and uncoupling. These studies identify mitochondrial ROS induction in brown adipose tissue as a mechanism that supports UCP1-dependent thermogenesis and whole-body energy expenditure, which opens the way to improved therapeutic strategies for combating metabolic disorders.
body temperature of mice without cold stress (Fig. 1d) , and equimolar injections of decylTPP, the mitochondria-targeting moiety lacking the antioxidant group, had no significant effect on body temperature during cold exposure (Extended Data Fig. 1b) .
While BAT and beige fat are the primary tissues for mediating adaptive thermogenesis, muscle shivering also plays an important role, particularly during the early thermogenic response 7 . Shivering was monitored directly by electromyography (EMG) after the transition from thermoneutrality to cold. As expected, by 30 min cold exposure substantial shivering was observed (Extended Data Fig. 1c-e ), which could be abrogated by the nicotinic acetylcholine receptor inhibitor curare (Extended Data Fig. 1c ). Importantly, treatment of mice with MitoQ before cold exposure caused no detectable change in shivering activity (Extended Data Fig. 1c-e ).
We next tested whether the hypothermic effects of depleting mitochondrial ROS depended on UCP1. Mice genetically lacking UCP1 (UCP1 −/− ) are sensitive to acute cold challenge, but maintain thermal homeostasis after gradual acclimation to temperatures below thermoneutrality through compensatory upregulation of alternative thermogenic pathways 8 . We injected wild-type (WT) and UCP1 −/− mice with MitoQ after gradual cold acclimation. Notably, UCP1 −/− mice were protected against the hypothermic effects of MitoQ (Fig. 1e ). Moreover, mice injected with MitoQ 10 min before β3-adrenergic stimulation by CL 316,243 (CL) 9 exhibited reduced CL-dependent oxygen consumption (Fig. 1f , g and Extended Data Fig. 1f ). These differences were observed in the absence of any significant changes in physical movement (Extended Data Fig. 1g ). Together, these data provide evidence that mitochondrial ROS support UCP1-dependent thermogenesis in vivo.
It is increasingly appreciated that mitochondrial ROS act as signalling molecules in physiology, which involves oxidative modification of sensitive cysteine thiol residues on proximal protein targets 10 . Strikingly, acute cold exposure drove substantial oxidation and depletion of the BAT glutathione pool (Extended Data Fig. 2a ). Furthermore, by performing quantitative profiling of in vivo protein thiol redox status in BAT using ratiometric labelling with iodoTMT (Extended Data Fig. 2b ), we found that BAT protein thiols became substantially more oxidized upon cold exposure ( Fig. 2a and Extended Data Fig. 2c ). Pathway analysis of those protein cysteine targets most substantially oxidized during thermogenesis revealed pathways involved in mitochondrial metabolism to be the most enriched ( Fig. 2b and Supplementary Table 1 ). Finally, we profiled levels of protein sulfenic acids 11 -the proximal reversible cysteine modification generated by lipid hydroperoxides and hydrogen peroxide 12 -and found them to be significantly elevated upon cold exposure (Fig. 2c) . These findings suggested that oxidation of mitochondrial thiols might be important for signalling ROS-dependent thermogenesis in BAT.
We examined this possibility using N-acetylcysteine (NAC), a cell-permeable cysteine precursor shown to increase the intracellular pool of reduced thiols 13 . Similar to what was observed with MitoQ, NAC treatment resulted in a significant decrease in core body temperature upon cold exposure (Fig. 2d ). This hypothermic activity suggests an effect on BAT function, as shivering was unaffected (Extended Data Fig. 1c-e ). Furthermore, acute elevation in oxygen consumption by CL administration was inhibited by NAC pretreatment ( Fig. 2e and Extended Data Fig. 2d ). Taken together, these findings suggest that increased mitochondrial ROS levels and consequent thiol oxidation play important roles in driving BAT thermogenesis in vivo.
The acute hypothermic effects of depleting mitochondrial ROS and altering thiol redox status occurred without any appreciable decrease in thermogenic gene expression in either BAT or inguinal white adipose tissue (Extended Data Fig. 3a, b ). In fact, some thermogenic gene markers were further elevated following MitoQ or NAC treatment, possibly representing a compensatory increase in expression due to functional compromise of thermogenic respiration (Extended Data Fig. 3a, b ). Furthermore, stimulation of the lipolytic machinery in BAT was comparable upon cold challenge after MitoQ treatment, suggesting this upstream driver of thermogenesis was not compromised (Extended Data Fig. 3c, d) . To test whether mitochondrial ROS might act as direct modulators of UCP1-dependent leak respiration, we examined primary brown adipocytes using cellular respirometry 14, 15 . As expected, adrenergic simulation by noradrenaline triggered a substantial increase in oxygen consumption rate (OCR; Fig. 3a and Extended Data Fig. 3e ); while inhibition of ATP synthase with oligomycin allowed for determination of leak respiration 14, 15 (Fig. 3a and Extended Data Fig. 3e ). Depletion of mitochondrial ROS with MitoQ and reducing the thiol redox status with NAC both inhibited leak respiration (Fig. 3a, b and Extended Data Fig. 3e, f) . Notably, these inhibitory effects were lost in adipocytes lacking UCP1 (Fig. 3c, d and Extended Data Fig. 3g , h).
Our findings indicated that ROS-supported thermogenesis relied on both UCP1 and cysteine thiol oxidation. So, we considered whether UCP1 cysteines were targets for oxidative modification during thermogenesis. We used a redox gel-shift method 16 to determine whether BAT mitochondrial ROS drive cysteine-centred oxidative modifications on UCP1 in vivo. This approach labels reversibly oxidized protein cysteines with a polyethylene glycol maleimide, allowing for their determination by immunoblotting after SDS-polyacrylamide gel electrophoresis 16 (Extended Data Fig. 3i ). In BAT from mice housed at thermoneutrality, UCP1 existed predominantly in a cysteine non-oxidized form (Fig. 3e ). However, upon cold challenge cysteine oxidation increased on UCP1 in a time-dependent manner ( Fig. 3e ). Calibration of UCP1 cysteine shifts indicated that a single cysteine site was redox modified during thermogenesis (Extended Data Fig. 4a -c), and this modification did not appear to participate in intermolecular disulfide bridging (Extended Data Fig. 4d ). Notably, pharmacological reduction of BAT thiol status with NAC, which results in hypothermia ( Fig. 2d ), diminished UCP1 cysteine thiol oxidation upon cold exposure ( Fig. 3f ).
So, ROS-supported thermogenesis in BAT both depended on UCP1 ( Fig. 1e ) and acted directly on UCP1 cysteine(s) by oxidative modification ( Fig. 3e, f) . To examine the role of cysteine oxidation on UCP1 function, we first identified the site modified during thermogenesis. We profiled UCP1 cysteines for sulfenic acid modifications in vivo by selective dimedone labelling and mass spectrometry 17 (Extended Data Fig. 4e ) after acute cold exposure. We identified six of seven UCP1 cysteines, five of which were identified exclusively in the unmodified (N-ethyl maleimide (NEM)-labelled) form (Extended Data Fig. 4f and Supplementary Data File 1). However, UCP1 Cys253 was identified in the sulfenylated (dimedone-labelled) form ( Fig. 4a , and (c) mitochondrial hydrogen-peroxidedependent oxidation of Prx3. Oxidized Prx3 was assessed using the redox gel shift method described in Methods. MM, molecular mass. Cys. ox., cysteine oxidation. For uncropped scans see Supplementary Figs 1-3. d, Effect of i.p. MitoQ on core body temperature after acute cold exposure (n = 10). e, Effect of i.p. MitoQ on core body temperature of WT and UCP1 −/− mice after 4 °C acclimation (n = 10; UCP1 −/− n = 8). f, Oxygen consumed acutely before and after i.p. CL ± MitoQ (n = 5). g, Oxygen consumed 3 h before and after i.p. CL ± MitoQ (n = 8). Data are mean ± s.e.m. of at least four mouse replicates. *P < 0.05, ***P < 0.001 (two-tailed Student's t-test for pairwise comparisons, one-way/two-way analysis of variance (ANOVA) for multiple comparisons involving one/two independent variables).
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and Supplementary Data File 1). Moreover, sulfenic acid occupancy on Cys253 increased significantly upon acute cold exposure ( Fig. 4b ).
Quantification of dimedone-labelled Cys253 provided an estimate of sulfenylation status during cold exposure (8.4%; Fig. 4b ). However, owing to the unstable nature of protein sulfenic acids 18 this must be considered a significant under-representation of in vivo levels of this modification.
Since UCP1 Cys253 was identified as a redox-sensitive site for which modification correlated with thermogenesis, we investigated the potential structural and functional importance of this residue. We modelled UCP1 on the structure of the homologous mitochondrial ATP/ADP carrier (AAC) 19 (Fig. 4c and Extended Data Fig. 5a ). This structure represents the matrix-closed 'c-state' of the carrier 19 , which for UCP1 is maintained by inhibitory binding of cytosolic purine nucleotides 1, 20 .
Examining the environment of the Cys253 thiol indicated that it resides at an interface between two matrix-facing helices. These helices contain residues highly conserved across the carrier family that stabilize the 'c-state' by inter-helical hydrophobic interactions and a hydrogen bond 21, 22 (Fig. 4d and Extended Data Fig. 5b ). This region forms the opposing face of the cytosolic cavity where inhibitory nucleotide binding is thought to occur 23, 24 , and is proximal to a putative site of cardiolipin binding on UCP1 21 (Fig. 4d) . Notably, modelling a sulfenic acid modification on the Cys253 thiol suggested that these 'c-state' interactions could be destabilized owing to local electrostatic effects (Extended Data Fig. 5b ). Thus, on the basis of this structural model, Cys253 oxidation status could play a role in determining stability of the matrix closed 'c-state' of UCP1, and sensitivity to β-adrenergic activation and uncoupling.
In the cellular milieu, UCP1 is inhibited by endogenous purine nucleotides, and this inhibition can be overcome by β-adrenergic stimulation of lipolysis and activation of UCP1-dependent respiration 1, 15 . A prediction of the above model is that altering Cys253 status should specifically modulate sensitivity to adrenergic activation of the purine nucleotide inhibited 'c-state' of UCP1 1, 20 . To test this, in UCP1 −/− brown adipocytes we separately transduced WT UCP1 and seven mutants, each having one of the seven cysteine residues contained in the protein replaced with an alanine. We titrated UCP1 transduction to recapitulate RNA and protein abundance observed in WT brown adipocytes (Extended Data Figure 6a -d). In all cases, basal and maximal respiration was indistinguishable between UCP1 −/− brown adipocytes, UCP1 −/− adipocytes transduced with WT UCP1, and UCP1 −/− adipocytes transduced with each of the seven UCP1 Cysmutants (Extended Data Fig. 6e , f). This agreed with previous studies indicating that UCP1 cysteines are not critical for protein stability and mitochondrial viability 25 .
The UCP1 Cys-mutant cells were subjected to noradrenaline and oligomycin to examine the effect of adrenergic activation on leak respiration. Noradrenaline stimulated rapid oxidation of protein cysteine residues (Extended Data Fig. 6g ) that was concomitant with increases in OCR (Extended Data Fig. 6h ). As expected, adipocytes lacking UCP1 exhibited a substantial reduction in respiration compared with WT UCP1 cells after 100 nM noradrenaline and oligomycin treatment, with ~35% of total leak OCR determined to be UCP1-dependent ( Fig. 4e ). Although replacing most UCP1 cysteines with alanine sites had no effect (Extended Data Fig. 7a-e ), individual modification of Cys253 substantially inhibited UCP1-dependent leak respiration ( Fig. 4f ). Interestingly, individual modification of Cys224 also inhibited UCP1 leak respiration (Extended Data Fig. 7f ). We additionally generated a C224A/C253A double mutant (Extended Data Fig. 6c, d) , which exhibited compromise of UCP1-dependent 
respiration comparable to the individual mutations (Extended Data Fig. 7g ). Replacement of the redox-sensitive Cys253 inhibited adrenergic activation of UCP1 by noradrenaline, so we next tested whether this site played an obligatory or sensitizing role in this context. To do so, we titrated noradrenaline (50-2,000 nM) to trigger variable levels of adrenergic stimulation in brown adipocytes (Extended Data Fig. 8a ). All concentrations of noradrenaline were sufficient to activate WT UCP1dependent leak respiration, which was consistently ~25-35% of total leak respiration ( Fig. 4g and Extended Data Fig. 8b ). UCP1-dependent respiration in C253A cells was substantially inhibited after stimulation with 50 nM noradrenaline; however, this inhibition was overcome dose-dependently by increasing noradrenaline concentrations ( Fig. 4g) . Thus, increased adrenergic stimulus could overcome inhibition by Cys253 replacement, suggesting that Cys253 plays a sensitizing (as opposed to an obligatory) role in adrenergically stimulated uncoupled respiration by UCP1. In contrast, exposure to variable adrenergic stimulus did not substantially modify the degree of inhibition of UCP1dependent leak respiration in UCP1 C224A cells (Extended Data Fig. 8c ). So, as opposed to a specific effect through altering sensitivity to adrenergic activation as in the case of Cys253, Cys224 replacement may alter UCP1 structure/function more generally.
Moreover, permeabilizing adipocytes to dilute cytosolic purine nucleotides resulted in uncoupled respiration that was indistinguishable between WT and C253A cells (Extended Data Fig. 8d ), and could be abrogated by sequestering of endogenous free fatty acids with BSA (Extended Data Fig. 8d ). In this nucleotide-diluted state, WT and C253A UCP1 cells exhibited a comparably low membrane potential (Δψ) as assessed by tetramethylrhodamine methyl ester (TMRM) fluorescence (Extended Data Figure 8e ). As expected, titration of GDP resulted in an increase in Δψ in UCP1 WT cells owing to GDPdependent inhibition of UCP1 1,20 (Extended Data Fig. 8f ). Notably, the C253A and C224A/C253A mutants exhibited increased sensitivity to GDP-dependent inhibition (Extended Data Fig. 8f ).
Taken together, these data indicate that acute regulation of thermogenesis in vivo can be supported by elevation of mitochondrial ROS levels. The thermogenic actions of mitochondrial ROS involve consequent oxidation of BAT cellular thiols, and UCP1-the major . c, d, Structure of (c) human UCP1 modelled on the AAC crystal structure and (d) Cys253 in a hydrophobic pocket between two matrix facing helices. IMS, intermembrane space. e, f, Basal, maximal, and UCP1-dependent OCR of UCP1 −/− brown adipocytes ± transduction with (e) WT UCP1 (WT n = 7; UCP1 −/− n = 6) or (f) UCP1 C253A (WT n = 17; C253A n = 19). KO, knockout. g, UCP1-dependent leak respiration after stimulation by various concentrations of noradrenaline (50 nM noradrenaline n = 9; 100 nM noradrenaline n = 7; 500 nM noradrenaline n = 8; 2,000 nM noradrenaline n = 6). Comparison of UCP1 WT and C253A indicates that degree of UCP1 inhibition by C253A is inversely correlated with noradrenaline concentration (n = 19; 100 nM WT noradrenaline; n = 17,500 nM noradrenaline n = 18; 2,000 nM noradrenaline n = 10). h, A model of sensitization of UCP1-mediated uncoupling by mitochondrial ROS. Data are mean ± s.e.m. of at least five mouse replicates or cell replicates for respirometry experiments. *P < 0.05, **P < 0.01 (two-tailed Student's t-test for pairwise comparisons).
thermogenic effector-is a target of thiol oxidation. We identify UCP1 Cys253 as a sulfenylation site that is increasingly modified during thermogenesis, and provide evidence that this residue can modulate sensitivity to activation of UCP1-dependent thermogenic respiration.
While UCP1 is identified here as a target of redox modification during thermogenesis, it is likely that other functional target proteins exist, which may act together to support thermogenic respiration. In addition to establishing a role for thiol redox signalling in thermogenesis in vivo, these findings provide insight into the longstanding investigations on the relationship between mitochondrial ROS and UCP1 (refs 1, 2, 26, 27) . Interestingly, studies in this area have relied largely on the use of isolated mitochondria and reconstituted systems. Our data suggest that redox regulation of UCP1-dependent respiration is particularly relevant in adipocytes and in vivo where both redox homeostasis and free fatty-acid concentrations are subject to strict endogenous regulation; parameters that are necessarily divergent from in vitro conditions. Notably, a role for thiol redox status and UCP1-dependent uncoupling has been suggested in isolated BAT mitochondria 28 , while the importance of superoxide in particular for modulating UCP1 function is the subject of debate 1, 2, 26, 27 . Previous investigation using a manganese superoxide dismutase transgenic mouse model suggested that matrix superoxide did not modify UCP1 function 27 . This previous work suggests that the role of thiol redox status in UCP1-dependent respiration detailed here is not directly mediated by matrix superoxide, but reliant on other ROS and related molecules the levels of which are not compromised by elevated manganese superoxide dismutase expression 10 .
Our data are consistent with a model whereby redox modification of Cys253 sensitizes purine nucleotide inhibited UCP1 to uncoupling due to acute adrenergic stimulus ( Fig. 4h ), which is compatible with fatty-acid-mediated activation and shuttling 20 . This model reconciles the apparent sensitizing role of both redox status and UCP1 Cys253 with the sufficient role of fatty acids for UCP1-dependent uncoupling 1 , as well as previous observations that cysteines are not essential for UCP1 activity in reconstituted systems 25 . However, previous study of UCP1 cysteines used yeast expression systems that are subject to protein misfolding and artefactual uncoupling 29 . Although Cys224 was not identified here as a target for reversible redox modification it appears to affect UCP1-dependent respiration, albeit distinctly from the sensitizing role of Cys253. It could be that this site is modified by other ROS-dependent species that are known to interact with UCP1 cysteines 30 . Additionally, these sites may also be important for UCP1 structure/function independent of redox-modification. Finally, it is worth noting that UCP1 Cys253 is conserved to a high degree across several mitochondrial carriers, including UCP2, UCP3, and AAC. This suggests that redox modification of this site may be a pervasive signalling modality for mitochondrial carriers in physiology and pathophysiology.

METHODS
Animal procedures and ethics statement.
Animal experiments were performed according to procedures approved by the Institutional Animal Care and Use Committee of the Beth Israel Deaconess Medical Center. Unless otherwise stated, mice used were male C57BL/6J (8-12 weeks of age; Jackson Laboratories), and housed in a temperature-controlled (20-22 °C) room on a 12 h light/dark cycle. In vivo compound administration. All compounds administered to mice in vivo were injected at the stated dose i.p. 10 min before subsequent interventions unless otherwise stated. Body temperature and cold exposure. Body temperature and cold exposure experiments were assessed using a mouse rectal probe (World Precision Instruments). When studying acute activation of thermogenesis, mice were housed from birth at 20-22 °C to allow for recruitment of thermogenic adipose tissue 7 . Before individual housing at 4 °C, mice were placed at thermoneutrality (30 °C) for 3 days which allows both for maintenance BAT UCP1 protein content 31 and for measurement of acute induction of BAT thermogenesis upon cold exposure. Upon exposure to 4 °C, temperature was measured every 30 min. When studying body temperature after 4 °C acclimation, WT and Ucp1 −/− mice (equal numbers of male and female mice in each group) were acclimated using established protocols: mice were individually housed for 1 week at 15 °C, 1 week at 10 °C, and 24 h at 4 °C before the experiment. EMG determination of muscle shivering. Mice were individually restrained to limit non-shivering muscle activity and two EMG needle electrodes were inserted subcutaneously above the nuchal muscles in the back of the neck. EMG leads were connected to a computerized data acquisition system via a communicator. EMG was recorded at thermoneutrality to determine non-shivering basal nuchal muscle activity, before placement of mice at 4 °C. EMG data were collected and burst activity was determined as described previously 32 . Briefly, EMG data were collected from the implanted electrodes at a sampling rate of 2 kHz using LabChart 8 Pro Software (ADInstruments). The raw signal was converted to root mean square activity. Root mean square activity was analysed for shivering bursts in 10 s windows. Metabolic phenotyping. Whole-body energy metabolism was evaluated using a Comprehensive Lab Animal Monitoring System (CLAMS, Columbia Instruments). For 6 h measurements, mice were acclimated in the metabolic chambers for 48 h before experiments to minimize stress from the housing change. CO 2 and O 2 levels were collected every 12 or 32 min for each mouse over the period of the experiment. For acute measurements, CO 2 and O 2 levels were collected every 10 s. CL 316,243 (Sigma-Aldrich; 1 mg kg −1 ) was injected i.p. into mice at the indicated times. Assessment of mitochondrial aconitase inactivation in mouse BAT. Aconitase activity was measured as described previously 33 . In brief, after the relevant in vivo intervention mouse BAT was rapidly excised and homogenized in mitochondrial isolation buffer (250 mM sucrose, 2 mM EDTA, 10 mM sodium citrate, 0.6 mM MnCl 2 , 100 mM Tris-HCl, pH 7.4) followed by mitochondrial isolation by differential centrifugation. Samples (1-2 mg mitochondrial protein) were added to a 96-well plate and 190 ml assay buffer (50 mM Tris-HCl (pH 7.4), 0.6 mM MnCl 2 , 5 mM sodium citrate, 0.2 mM NADP + , 0.1% (v/v) Triton X-100, 0.4 U ml −1 ICDH). Absorbance was measured at 340 nm for 7 min at 37 °C. To control for mitochondrial content aconitase activity was normalized to citrate synthase activity 34 and expressed the result as a percentage of control levels. Assessment of lipid hydroperoxides in mouse BAT. Lipid hydroperoxide content in mouse BAT was estimated by rapid snap freezing of BAT tissue followed by lipid extraction and assessment using a modified ferric thiocyanate assay (Cayman Chemical Lipid Hyroperoxide Assay Kit) according to the manufacturer's instructions. Assessment of cysteine redox status by gel shift. Cysteine redox status of Prx3 and UCP1 was measured as described previously 16, 35 . After the relevant in vivo intervention, mouse BAT was rapidly excised and homogenized in 100 mM NEM, 1 mM EGTA, 50 mM Tris-HCl, pH 7.4. Samples were incubated at 37 °C for 5 min before the addition of SDS (2% final) and further incubation at 37 °C for 10 min. Incubations at 37 °C proceeded in a thermomixer at 1,300 r.p.m. Samples were then precipitated in five volumes of ice-cold acetone to remove excess NEM before resuspension in 1 mM EGTA, 2% SDS, 10 mM TCEP, 50 mM Tris-HCl, pH 7.4 containing a polyelthylene glycol polymer conjugated to maleimide (50 mM PEG-Mal). Resuspended samples were incubated for 30 min at 37 °C before a second acetone precipitation to remove excess PEG-Mal before sample resuspension and immunoblot detection by standard methods described below. For UCP1 experiments, to ensure gel shift signals were specific to reversible cysteine oxidation, oxidized samples were separately treated with TCEP before differential labelling as described above. Calibrating the number of UCP1 cysteines oxidized was achieved by treating TCEP-reduced samples with increasing proportions of Peg-Mal:NEM to generate a cysteine-dependent ladder 35 . In addition, to ensure higher molecular mass signals were specific to UCP1, UCP1 antibody specificity was tested in BAT. It should be noted that while the UCP1 antibody used here is highly specific for UCP1 in BAT (Extended Data Fig. 4c ), the same antibody applied to cultured brown adipocyte samples can generate non-specific signals at molecular mass >35 kDa. So, the UCP1 gel shift assay as described here is only compatible with in vivo tissue experiments. Assessment of BAT-reduced and -oxidized glutathione content by mass spectrometry. Reduced and oxidized glutathione were profiled in negative ionization mode by liquid chromatography tandem mass spectrometry (LC-MS) methods as described previously 36 . Data were acquired using an ACQUITY UPLC (Waters) coupled to a 5500 QTRAP triple quadrupole mass spectrometer (AB SCIEX). Tissue homogenates (30 μl) were extracted using 120 μl of 80% methanol containing 0.05 ng μl −1 inosine-15 N 4 , 0.05 ng μl −1 thymine-d 4 , and 0.1 ng μl −1 glycocholate-d 4 as internal standards (Cambridge Isotope Laboratories). The samples were centrifuged (10 min, 9,000g, 4 °C) and the supernatants (10 μl) were injected directly onto a 150 mm × 2.0 mm Luna NH2 column (Phenomenex). The column was eluted at a flow rate of 400 μl min −1 with initial conditions of 10% mobile phase A (20 mM ammonium acetate and 20 mM ammonium hydroxide (Sigma-Aldrich) in water (VWR)) and 90% mobile phase B (10 mM ammonium hydroxide in 75:25 v/v acetonitrile/methanol (VWR)) followed by a 10 min linear gradient to 100% mobile phase A. The ion spray voltage was −4.5 kV and the source temperature was 500 °C. Raw data were processed using MultiQuant 2.1 software (AB SCIEX) for automated peak integration. LC-MS data were processed and visually inspected using TraceFinder 3.1 software (Thermo Fisher Scientific). Assessment of BAT protein thiol redox status using iodoTMT. After the relevant in vivo intervention, mouse BAT was rapidly excised and homogenized in 20% (w/v) TCA to stabilize thiols. The homogenate was incubated on ice for 30 min and then pelleted for 30 min at 16,000g at 4 °C. The pellet was washed with 10% and 5% (w/v) TCA and then resuspended in 80 μl denaturing alkylating buffer (DAB; 6 M urea, 2% (w/v) SDS, 200 mM Tris-HCl, 10 mM EDTA, 100 μM DTPA, 10 μM neocuproine). The contents of one vial of iodoTMT 6 reagent (Thermo Scientific) was added to each of three biological replicate samples to label reduced cysteine residues at 37 °C and 1,300 r.p.m. for 1 h. Sample protein was precipitated with five volumes of ice-cold acetone, incubated at −20 °C for 2 h, and pelleted at 4 °C and 16,000g for 30 min. The amount of protein to be processed was optimized to ensure saturation of thiol labelling by the iodoTMT reagent as per the manufacturer's instructions. The pellet was washed twice with ice-cold acetone and then re-solubilized in 80 μl DAB containing 1 mM tris(2-carboxyethyl)phosphine (TCEP), reducing previously reversibly oxidised cysteine residues in the presence of a second, distinct iodoTMT 6 reagent. Proteins were incubated at 37 °C and 1,400 r.p.m. for 1 h, precipitated and resuspended for protease digestion. After digestion, iodoTMT-labelled cysteine-containing peptides were enriched using the anti-TMT resin as per the manufacturer's instructions. Profiling of redox-sensitive protein targets. Proteins with cysteine thiols exhibiting differential redox status (defined as >10% shift in cysteine oxidation status upon cold exposure) were assessed for Gene Ontology (GO) term enrichment 37 . The total identified population of cysteine thiol containing proteins was used as the reference background. Enriched GO terms were filtered after benjamini-hochberg correction at an adjusted P value <0.1. All data analysis used R (R Core Team, Vienna, Austria, http://www.R-project.org). Assessment of protein thiol sulfenic acids. Tissue or cellular samples were prepared adapting a protocol used previously to stabilize endogenous protein sulfenic acids 38 . Briefly, samples were homogenized in 50 mM Tris base, containing 100 mM NaCl, 100 μM DTPA, 0.1% SDS, 0.5% sodium deoxycholate, 0.5% Triton-X 100, 5 mM dimedone. To minimize lysis-dependent oxidation, buffers were bubbled with argon before use. Samples were incubated for 15 min at room temperature, at which point SDS was added to a final concentration of 1% and samples were incubated for a further 15 min. After dimedone treatment, 10 mM TCEP and 50 mM NEM were added and samples were incubated for a further 15 min at 37 °C to reduce and alkylate all non-sulfenic acid protein cysteine residues. Protein sulfenic acids were then assessed by immunoblotting against dimedone (1:1,000 antibody dilution).
Targeted assessment of UCP1 cysteine sulfenylation status using dimedone-MS.
After dimedone and NEM labelling of samples as described above, samples were resolved by SDS-PAGE and bands in the UCP1 containing region of the gel (30-35 kDa) were excised, destained with acetonitrile and subjected to dehydration by a speed vacuum concentrator. Gel bands were rehydrated with digestion buffer (75 μl of 50 mM HEPES and 500 ng of trypsin (Promega) and subjected to 12 h of digestion at 37 °C. Peptides were extracted and labelled with TMT 10 reagents (Thermo Fisher) as previously described 39 .
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Protein digestion. Protein pellets were dried and resuspended in 8 M urea containing 50 mM HEPES (pH 8.5). Protein concentrations were measured by BCA assay (Thermo Scientific) before protease digestion. Protein lysates were diluted to 4 M urea and digested with LysC (Wako, Japan) in a 1/100 enzyme/protein ratio overnight. Protein extracts were diluted further to a 1.0 M urea concentration, and trypsin (Promega) was added to a final 1/200 enzyme/protein ratio for 6 h at 37 °C. Digests were acidified with 20 μl of 20% formic acid (FA) to a pH ~2, and subjected to C18 solid-phase extraction (Sep-Pak, Waters). LC-MS/MS parameters. All spectra were acquired using an Orbitrap Fusion mass spectrometer (Thermo Fisher) in line with an Easy-nLC 1000 (Thermo Fisher Scientific) ultra-high pressure liquid chromatography pump. Peptides were separated onto a 100 μM inner diameter column containing 1 cm of Magic C4 resin (5 μm, 100 Å, Michrom Bioresources) followed by 30 cm of Sepax Technologies GP-C18 resin (1.8 μm, 120 Å) with a gradient consisting of 9-30% (ACN, 0.125% FA) over 180 min at ~250 nl min −1 . For all LC-MS/MS experiments, the mass spectrometer was operated in the data-dependent mode. We collected MS 1 spectra at a resolution of 120,000, with an AGC target of 150,000 and a maximum injection time of 100 ms. The ten most intense ions were selected for MS 2 (excluding 1 Z-ions). MS 1 precursor ions were excluded using a dynamic window (75 s ± 10 ppm). The MS 2 precursors were isolated with a quadrupole mass filter set to a width of 0.5Th. For the MS 3 based TMT quantitation, MS 2 spectra were collected at an AGC of 4,000, maximum injection time of 150 ms, and CID collision energy of 35%. MS 3 spectra were acquired with the same Orbitrap parameters as the MS 2 method except HCD collision energy was increased to 55%. Synchronousprecursor-selection was enabled to include up to six MS 2 fragment ions for the MS 3 spectrum. Data processing and MS 2 spectra assignment. A compilation of in-house software was used to convert .raw files to mzXML format, as well as to adjust monoisotopic m/z measurements and erroneous peptide charge state assignments. Assignment of MS 2 spectra was performed using the SEQUEST algorithm 40 . All experiments used the Mouse UniProt database (downloaded 10 April 2014) where reversed protein sequences and known contaminants such as human keratins were appended. SEQUEST searches were performed using a 20 ppm precursor ion tolerance, while requiring each peptide's amino/carboxy (N/C) terminus to have trypsin protease specificity and allowing up to two missed cleavages. IodoTMT tags on cysteine residues residues (+329.226595 Da) was set as static modifications, while methionine oxidation (+15.99492 Da) was set as variable modifications. For targeted assessment of UCP1 cysteine sulfenylation, TMT tags on lysine residues and peptide N termini (+229.16293 Da), NEM on cysteine residues (+125.047679 Da) were set as static modifications and oxidation of methionine residues (+15.99492 Da) and dimedone on cysteine residues (+13.020401 Da versus NEM) as variable modifications. Determination of sulfenylation status of the Cys253 peptide was determined by comparing TMT reporter ion abundance of the dimedone-alkylated and NEM-alkylated peptides as a proportion of total precursor ion intensity. An MS 2 spectra assignment false discovery rate of less than 1% was achieved by applying the target-decoy database search strategy 41 . Protein filtering was performed using an in-house linear discrimination analysis algorithm to create one combined filter parameter from the following peptide ion and MS2 spectra metrics: XCorr, ΔCn score, peptide ion mass accuracy, peptide length and missed-cleavages 42 . Linear discrimination scores were used to assign probabilities to each MS 2 spectrum for being assigned correctly, and these probabilities were further used to filter the data set to a 1% protein-level false discovery rate. Determination of iodoTMT reporter ion intensities and quantitative data analysis. For quantification, a 0.03m/z window centred on the theoretical Th value of each reporter ion was used for the nearest signal intensity. Reporter ion intensities were adjusted to correct for the isotopic impurities from the different TMT reagents (manufacturer specifications). The signal to noise values for all peptides were summed within each TMT channel. For each peptide, a total minimum sum signal to noise value of 200 and an isolation purity greater than 70% was required 43 . Percentage cysteine oxidation status of protein thiols was calculated as the percentage of the cysteine containing peptide (total or mitochondrial) labelled with iodoTMT (129, 130, 131) for each condition over the sum of the reduced peptide labelled with iodoTMT (126, 127, 128) plus reversibly oxidized labelled peptide (129, 130, 131): (oxidized peptide 129, 130, 131)/(reduced peptide 126, 127, 128 + oxidized peptide 129, 130, 131) × 100. Primary brown adipocyte preparation and differentiation. Interscapular brown adipose stromal vascular fraction was obtained from 2-to 6-day-old pups as described previously 44 . Interscapular brown adipose was dissected, washed in PBS, minced, and digested for 45 min at 37 °C in PBS containing 1.5 mg ml −1 collagenase B, 123 mM NaCl, 5 mM KCl, 1.3 mM CaCl 2 , 5 mM glucose, 100 mM HEPES, and 4% essentially fatty-acid-free BSA. Tissue suspension was filtered through a 40 μm cell strainer and centrifuged at 600g for 5 min to pellet the SVF. The cell pellet was resuspended in adipocyte culture medium and plated. Primary brown pre-adipocytes were counted and plated in the evening, 12 h before differentiation at 15,000 cells per well of a seahorse plate. Pre-adipocyte plating was scaled according to surface area. The following morning, brown pre-adipocytes were induced to differentiate for 2 days with an adipogenic cocktail (1 μM rosiglitazone, 0.5 mM IBMX, 5 μM dexamethasone, 0.114 μg ml −1 insulin, 1 nM T3, and 125 μM Indomethacin) in adipocyte culture medium. Two days after induction, cells were re-fed every 48 h with adipocyte culture medium containing 1 μM rosiglitazone and 0.5 μg ml −1 insulin. Cells were fully differentiated by day 5 after induction. Primary brown adipocyte cellular respirometry. Cellular OCR of primary brown adipocytes was determined using a Seahorse XF24 Extracellular Flux Analyzer. Adipocytes were plated and differentiated in XF24 V7 cell culture microplates. Before analysis adipocyte culture medium was changed to DMEM respiration medium lacking NaHCO 3 (Sigma), and including 1.85 g l −1 NaCl, 3 mg l −1 phenol red, 2% fatty-acid-free BSA, 1 mM sodium pyruvate, pH 7.4. Basal respiration was determined to be the OCR in the presence of substrate alone. ATP-synthaseindependent respiration was determined after addition of 2.5 μM oligomycin. Unless otherwise stated, leak respiration was determined after addition of 2.5 μM oligomycin and 100 nM noradrenaline. Maximal respiration was determined after addition of 2 μM FCCP. To determine OCR after plasma membrane permeabilization, cells were treated with 50 μg ml −1 saponin, and sequestration of free fatty acids after permeabilization was achieved through addition of 2% fatty-acid-free BSA. Cloning, construct design, and site-directed mutagenesis. RNA from murine BAT was reverse-transcribed and used as template for PCR of Ucp1. Sequences for Ucp1 amplification were as follows: sense, CAC CAT GGT GAA CCC GAC AAC TTC C; antisense, TTA TGT GGT ACA ATC CAC TG. PCR fragments were gel-purified and cloned into the pENTR/D-TOPO entry vector according to the manufacturer's instructions (Invitrogen; K2400). Cloned Ucp1 was shuttled into the pAd/CMV/V5-DEST Gateway vector, and confirmed by sequencing. Cysteine mutants were generated using the Quik-Change site-directed muta genesis kit (Stratagene). Primers for generating mutants were as follows: Ucp1 C24A forward 5′-AGCCGGAGTTTCAGCTGCCCTGGCAGATATCATC-3′, reverse 5′-GATGATATCTGCCAGGGCAGCTGAAACTCCGGCT-3′; Ucp1 C188A forward 5′-TGAGAAATGTCATCATCAATGCTACAGAGCTGGTAACATATG-3′, reverse 5′-CATATGTTACCAGCTCTGTAGCATTGATGATGACATTTCTCA-3′; UCP1 C213A forward 5′-TGGCAGATGACGTCCCCGCCCATTTACT GTCAGCTC-3′, reverse 5′-GAGCTGACAGTAAATGGGCGGGGACG TCATCTGCCA-3′; Ucp1 C224A forward 5′-TCTTGTTGCCGGGTT TGCCACCACACTCCTGGCC-3′, reverse 5′-GGCCAGGAGTGTGGTG GCAAACCCGGCAACAAGA-3′; Ucp1 C253A forward 5′-CCCAAGC GTACCAAGCGCTGCGATGTCCATGTAC-3′, reverse 5′-GTACATGGAC ATCGCAGCGCTTGGTACGCTTGGG-3′; Ucp1 C287A forward 5′-GGAAC GTCATCATGTTTGTGGCCTTTGAACAGCTGAAAAAAG-3′, reverse 5′-CTTTTTTCAGCTGTTCAAAGGCCACAAACATGATGACGTTCC-3′; Ucp1 C304A forward 5′-CAGACAGACAGTGGATGCTACCACATAAGGATCC-3′, reverse 5′-GGATCCTTATGTGGTAGCATCCACTGTCTGTCTG-3′. Production of adenovirus and transduction of cysteine-null UCP1 mutants. pAd/CMV/V5-DEST/Ucp1 was linearized with PacI and transfected (3 μg) into 293A cells with lipofectamine 2000 (Invitrogen). Crude adenovirus was generated according to the manufacturer's instructions (Invitrogen; V493-20). Crude adenovirus was amplified by infecting 293A cells, and purified using the Fast Trap Adenovirus Purification and Concentration Kit (EMD Millipore). Virus was quantified by examining viral DNA. Briefly, viral particles were treated with Proteinase K and DNA was isolated with phenol and chloroform/isoamylalcohol (24:1). Preliminary experiments with titrations of viral transductions in Ucp1 −/− adipocytes were used to determine the amount of virus yielding a Ucp1 messenger RNA (mRNA) and protein level similar to the level detected from Ucp1 +/+ adipocytes. For subsequent experiments, primary brown adipocytes were transduced with purified adenovirus in the evening of day 3 after differentiation with medium replacement the following morning. Adipocytes were used for experiments on day 5 after differentiation. Structural modelling of UCP1. A comparative model of UCP1 was built by using the structure of the bovine AAC 19 . This structure corresponds to the 'c-state' of the carrier-open to the mitochondrial inner membrane. The protein sequence of human UCP1 was taken from UniProt. To align the AAC and UCP1 sequences, MUSCLE 45 and manual editing in Jalview 46 were used. To improve the quality of the comparative models, the alignments were edited to remove the N-and C-terminal residues of the UCP1 sequences that did not align with resolved residues in the AAC structure, and to place gaps in the UCP1 sequences so as to minimize the distance between these residues in the initial target structure. Fifty comparative models of human UCP1 were built from the AAC structure and the sequence alignment by using MODELLER. The structure with the lowest MODELLER energy score was taken as the best representative structure. The cardiolipin molecules of the AAC were added to the modelled UCP1 structure by aligning the two structures, and copying the lipid molecules 21, 22, 47 . This structure was examined and figures produced by using the PyMOL molecular visualization system (PyMOL Molecular Graphics System, version 1.4.1, Schrödinger). Assessment of superoxide levels in primary brown adipocytes. ROS production was estimated by oxidation of DHE and ratiometric assessment as described previously 33 . Cells were plated and differentiated onto 96-well plates suitable for fluorescence analysis. Before imaging, cell media was removed and replaced with imaging buffer (156 mM NaCl, 1.25 mM KH 2 PO 4 , 3 mM KCl, 2 mM MgCl 2 , 10 mM HEPES, pH 7.4) supplemented with 1 mM sodium pyruvate. Cells were loaded with 5 μM DHE (Invitrogen), which remained present throughout the time course. DHE was excited at 355 nm and the emitted signal was acquired at 460 nm. Oxidized DHE was excited at 544 nm and emission was acquired at 590 nm. Assessment of mitochondrial membrane potential in permeabilized primary brown adipocytes. Mitochondrial membrane potential was measured in permeabilized cells using TMRM (Life Technologies) in dequench mode. In this mode, mitochondrial depolarization causes redistribution of a high concentration of signal quenched TMRM from mitochondria to the cytosol, such that the lower concentration results in dequenching and an increase in fluorescence 48 . Cells were pre-loaded at room temperature with imaging buffer containing 1 μM TMRM. TMRM fluorescence was excited at 544 nm and emission was collected at 590 nm. Quantitative RT-PCR. Total RNA was extracted from frozen tissue using TRIzol (Invitrogen), purified with RNeasy Mini spin columns (QIAGEN) and reverse transcribed using a High-Capacity cDNA Reverse Transcription kit (Applied Biosystems). The resultant complementary DNA (cDNA) was analysed by quantitative PCR with reverse transcription (qRT-PCR). Briefly, 20 ng cDNA and 150 nmol of each primer were mixed with SYBR GreenER qPCR SuperMix (Applied Biosystems). Reactions were performed in a 384-well format using an ABI PRISM 7900HT real time PCR system (Applied Biosystems). Relative mRNA levels were calculated using the comparative CT method and normalized to cyclophilin mRNA. The following primers were used in these studies: Cyclophilin forward 5′-GGAGATGGCACAGGAGGAA-3′, reverse 5′ -GCCCGTAGTGCT TCAGCT T-3′ ; Ucp1 for ward 5′ -ACTGCCACACCTCCAGTCATT-3′, reverse 5′-CTTTGCCTCACTCAG GATTGG-3′; Dio2 forward 5′-CAGTGTGGTGCACGTCTCCAATC-3′, reverse 5′ -TGAACCAAAGT TGACCACCAG-3′ ; Pgc1α for ward 5′-CCCTGCCATTGTTAAGACC-3′, reverse 5′-TGCTGCTGTTCCTGTTTTC-3′; PPAR-γ forward 5′-TGAAAGAAGCGGTGAACCACTG-3′, reverse 5′-TGGCATCTCTGTGTCAACCATG-3′; Pgc1β forward 5′-CTGACGT GGACGAGCTTTCA-3′, reverse 5′-CGTCCTTCAGAGCGTCAGAG-3′; Nrf2 forward 5′-CCAGCTACTCCCAGGTTGCC-3′, reverse 5′-GGGA TATCCAGGGCAAGCGA-3′; Ap2 5′-AAGGTGAAGAGCATCATAACCCT-3′, reverse 5′-TCACGCCTTTCATAACACATTCC-3′. Glycerol release. Adipocytes were incubated in respiration medium absent BSA and treated with indicated concentrations of noradrenaline for 2 h before collection of medium and quantification of glycerol using free glycerol reagent (Sigma-Aldrich) relative to glycerol standard and normalized to protein content. Statistical analyses. Data were expressed as mean ± s.e.m. and P values were calculated using two-tailed Student's t-test for pairwise comparisons, one-way ANOVA for multiple comparisons, and two-way ANOVA for multiple comparisons involving two independent variables. ANOVA analyses were subjected to Bonferroni's post hoc test. Sample sizes were determined on the basis of previous experiments using similar methodologies. For in vivo studies, mice were randomly assigned to treatment groups. Mass spectrometric analyses were blinded to experimental conditions. 6) . c, Calibration of specificity of UCP1 antibody in BAT. d, Reducing and non-reducing SDS-PAGE analysis of UCP1 to monitor cysteine-dependent and -independent inter-protein interactions during acute cold exposure. e, Scheme for identification of sulfenylated cysteines on UCP1 by dimedone labelling and mass spectrometry. After acute cold exposure, BAT protein thiols are differentially alkylated with dimedone to selectively label sulfenylated thiols and NEM to label non-sulfenylated thiols. Samples are subjected to trypsin digestion, followed by Lys-TMT labelling, and MS quantification of UCP1 cysteine containing peptides in their dimedone and NEM alkylated forms. Two technical points should be noted in this strategy when interpreting relative quantitation of NEM and dimedone-alkylated peptides. First, these differently alkylated peptides may not necessarily ionize with the same efficiency. Second, NEM is reported to react with sulfenic acids albeit less efficiently than with free thiols 50 , which should be factored in when considering the order of addition of dimedone/ NEM and potential underestimation of sulfenylation status. f, Top: amino-acid sequence alignment of UCP1 proteins highlighting the candidate cysteine residues contained within the mouse protein and their level of conservation across various species. Bottom: summary of MS determination of UCP1 cysteine sulfenylation status. Six of seven UCP1 cysteines were identified, with all but one being identified exclusively in the unmodified (NEM-alkylated state). Cys253 is identified as dimedone labelled, indicating that it is a site for sulfenylation. Extended Data Figure 6 | Assessing transduced UCP1 constructs, OCR, and sulfenylation in brown adipocytes. a, Quantitative PCR analysis of UCP1 mRNA in WT, and UCP1 −/− brown adipocytes transduced with WT and cysteine null UCP1 mutants (n = 4). b, Immunoblot of UCP1 protein in WT and UCP1 −/− brown adipocytes transduced with WT and cysteine null UCP1 mutants. c, Immunoblot analysis of UCP1 protein in UCP1 −/− brown adipocytes transduced with C224A/C253A double mutant compared with WT. d, Densitometry analysis of transduced UCP1 forms relative to WT across separate transduction experiments (n = 4; C224A/C253A n = 3). e, f, Summary of basal (e) and maximal (f) OCR of primary brown adipocytes containing cysteine-null UCP1 mutants. Raw OCR values provided in Extended Data Fig. 7 . g, Immunodetection of protein sulfenic acid levels in primary brown adipocytes in the seconds after treatment with 100 nM noradrenaline. h, Time course of brown adipocyte OCR after stimulation with 100 nM noradrenaline (n = 12). Data are mean ± s.e.m. of at least three replicates.
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